← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ascribe Bioscience Inc.
Ithaca, NY
$4,948,055
Total funding
5
Grants
Funding over time
peak $1.7M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,324,125 · 3
NSF$1,623,930 · 2
By mechanism
R44$2,771,996 · 1
—$1,623,930 · 2
R41$552,129 · 2
Investigators at Ascribe Bioscience Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: Controlling plant pathogens with novel seed treatments based on nematode-produced ascarosides$1,399,007
· FY2020 · TIP
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments$998,060
R44 · FY2022 · AI
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments$991,328
R44 · FY2023 · AI
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments$782,608
R44 · FY2024 · AI
Using novel pre-harvest, resistance-conferring treatments to prevent foodborne pathogenic outbreaks in produce$299,999
R41 · FY2022 · AI
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments$252,130
R41 · FY2020 · AI
SBIR Phase I: Controlling plant pathogens with novel seed treatments based on nematode-produced ascarosides$224,923
· FY2019 · TIP